Breaking News Instant updates and real-time market news.

NVO

Novo Nordisk

$41.53

-0.2 (-0.48%)

06:59
10/12/18
10/12
06:59
10/12/18
06:59

Novo Nordisk says Fiasp effective at controlling T1D kids' blood sugar levels

For children and adolescents living with type 1 diabetes, Fiasp could be an option to better manage their blood sugar levels, when used as part of a multiple daily injection routine, said Novo Nordisk. New data presented at the 44th Annual Conference of the International Society for Pediatric and Adolescent Diabetes showed that the study population receiving Fiasp achieved superior reductions in overall blood sugar levels, compared to the group on conventional insulin aspart, when both treatments were dosed at mealtime. In addition, significantly lower overall post-meal blood sugar levels were achieved with Fiasp compared to conventional insulin aspart, Novo Nordisk announced.

NVO Novo Nordisk
$41.53

-0.2 (-0.48%)

10/08/18
GUGG
10/08/18
INITIATION
GUGG
Buy
Novo Nordisk initiated with a Buy at Guggenheim
Guggenheim analyst Seamus Fernandez started Novo Nordisk with a Buy rating and DKK 361 price target, stating that he expects quality growth through 2020 and beyond " as long as GLP-1 category price discipline remains."
10/08/18
10/08/18
DOWNGRADE

Neutral
Novo Nordisk downgraded to Neutral on Eli Lilly competition at BofA/Merrill
As previously reported, BofA Merrill Lynch analyst Sachin Jain downgraded Novo Nordisk (NVO) to Neutral from Buy after he lowered his Ozempic forecasts beyond FY23 to account for possible competitive pressure from Eli Lilly's (LLY) GIP/GLP-1. While he does not see competitive pressure on Novo's Ozempic until FY23, he still sees that threat as a sufficient overhang given that the injectable GLP-1 franchise accounts for about 40% of his Novo growth forecast from FY19-23E and about 30% for FY23, Sachin tells investors. He lowered his price target on Novo shares to DKK305 from DKK380.
10/08/18
BOFA
10/08/18
DOWNGRADE
BOFA
Neutral
Novo Nordisk downgraded to Neutral from Buy at BofA/Merrill
10/05/18
PART
10/05/18
DOWNGRADE
PART
Hold
Novo Nordisk downgraded to Hold from Buy at Pareto

TODAY'S FREE FLY STORIES

FOCS

Focus Financial Partners

$30.59

0.27 (0.89%)

07:14
02/21/19
02/21
07:14
02/21/19
07:14
Earnings
Focus Financial Partners reports Q4 adj. EPS 51c, consensus 50c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 12

    Mar

GPI

Group 1 Automotive

$63.62

2.05 (3.33%)

07:14
02/21/19
02/21
07:14
02/21/19
07:14
Hot Stocks
Group 1 Automotive raises share repurchase authorization to $75M »

Group 1 Automotive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Mar

  • 06

    Mar

OGE

OGE Energy

$41.94

0.01 (0.02%)

07:13
02/21/19
02/21
07:13
02/21/19
07:13
Earnings
Breaking Earnings news story on OGE Energy »

OGE Energy sees FY19 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

AERI

Aerie Pharmaceuticals

$39.56

-1.25 (-3.06%)

07:13
02/21/19
02/21
07:13
02/21/19
07:13
Recommendations
Aerie Pharmaceuticals analyst commentary  »

Aerie Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 14

    Mar

  • 18

    Mar

OGE

OGE Energy

$41.94

0.01 (0.02%)

07:12
02/21/19
02/21
07:12
02/21/19
07:12
Earnings
OGE Energy reports Q4 EPS 27c, consensus 23c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

BRC

Brady

$47.35

0.59 (1.26%)

07:12
02/21/19
02/21
07:12
02/21/19
07:12
Earnings
Brady raises FY19 EPS view to $2.25-$2.35 from $2.20-$2.30, consensus $2.28 »

Backs FY19 organic sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 28

    Mar

VRCA

Verrica Pharmaceuticals

$10.99

-0.12 (-1.08%)

07:11
02/21/19
02/21
07:11
02/21/19
07:11
Initiation
Verrica Pharmaceuticals initiated  »

Verrica Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

ARRS

Arris

$31.65

0.025 (0.08%)

07:11
02/21/19
02/21
07:11
02/21/19
07:11
Earnings
Arris reports preliminary Q4 adjusted EPS 76c, consensus 75c »

Reports Q4 preliminary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEN

Wendy's

$17.64

-0.25 (-1.40%)

07:10
02/21/19
02/21
07:10
02/21/19
07:10
Hot Stocks
Wendy's approves new $225M share repurchase program »

At the end of 2018, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 06

    Mar

QEP

QEP Resources

$8.19

-0.08 (-0.97%)

07:10
02/21/19
02/21
07:10
02/21/19
07:10
Recommendations
QEP Resources analyst commentary  »

Elliott may push for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

BRC

Brady

$47.35

0.59 (1.26%)

07:10
02/21/19
02/21
07:10
02/21/19
07:10
Earnings
Brady reports Q2 EPS 55c, consensus 52c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 28

    Mar

AVB

AvalonBay

$194.14

-2.37 (-1.21%)

07:09
02/21/19
02/21
07:09
02/21/19
07:09
Downgrade
AvalonBay rating change  »

Citi downgrades AvalonBay…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

ARD

Ardagh Group

$12.98

0.32 (2.53%)

07:09
02/21/19
02/21
07:09
02/21/19
07:09
Hot Stocks
Breaking Hot Stocks news story on Ardagh Group »

Ardagh Group sees Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

ARD

Ardagh Group

$12.98

0.32 (2.53%)

07:08
02/21/19
02/21
07:08
02/21/19
07:08
Earnings
Ardagh Group sees FY19 adjusted EPS $1.60-$1.75, consensus $1.76 »

2019 outlook: Full year…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

IRT

Independence Realty Trust

$10.71

-0.01 (-0.09%)

07:08
02/21/19
02/21
07:08
02/21/19
07:08
Earnings
Independence Realty sees FY19 EPS 76c-80c, may not compare to consensus 24c 

Sees FY19 CFFO 74c-78c.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

WEN

Wendy's

$17.64

-0.25 (-1.40%)

07:08
02/21/19
02/21
07:08
02/21/19
07:08
Earnings
Wendy's sees FY20 global systemwide sales of approximately $11.5B »

Sees FY20 free cash flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 06

    Mar

ALB

Albemarle

$82.82

-0.305 (-0.37%)

07:08
02/21/19
02/21
07:08
02/21/19
07:08
Recommendations
Albemarle analyst commentary  »

Oppenheimer says remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 27

    Feb

  • 27

    Feb

BDC

Belden

$63.83

7.19 (12.69%)

07:08
02/21/19
02/21
07:08
02/21/19
07:08
Recommendations
Belden analyst commentary  »

Belden price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    May

  • 14

    May

  • 15

    May

MCRN

Milacron

$14.78

0.13 (0.89%)

07:08
02/21/19
02/21
07:08
02/21/19
07:08
Earnings
Milacron sees FY19 pro forma sales growth 0%-1%, consensus $1.28B »

In line with current…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

ARD

Ardagh Group

$12.98

0.32 (2.53%)

07:07
02/21/19
02/21
07:07
02/21/19
07:07
Earnings
Ardagh Group reports Q4 adjusted EPS 33c, consensus 28c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

GIL

Gildan Activewear

$34.17

-0.17 (-0.50%)

07:07
02/21/19
02/21
07:07
02/21/19
07:07
Earnings
Breaking Earnings news story on Gildan Activewear »

Gildan Activewear sees Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

IRT

Independence Realty Trust

$10.71

-0.01 (-0.09%)

07:07
02/21/19
02/21
07:07
02/21/19
07:07
Earnings
Independence Realty Trust reports Q4 EPS 16c, consensus 5c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

WEN

Wendy's

$17.64

-0.25 (-1.40%)

07:07
02/21/19
02/21
07:07
02/21/19
07:07
Earnings
Wendy's sees FY19 adjusted EPS growth of 3.5%-7%, consensus 66c »

Sees FY19 global…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 06

    Mar

BTX

BioTime

$1.16

-0.11 (-8.66%)

07:07
02/21/19
02/21
07:07
02/21/19
07:07
Initiation
BioTime initiated  »

BioTime initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 07

    Mar

GIL

Gildan Activewear

$34.17

-0.17 (-0.50%)

07:06
02/21/19
02/21
07:06
02/21/19
07:06
Earnings
Breaking Earnings news story on Gildan Activewear »

Gildan Activewear sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.